Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | KCNA1 | Q09470 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL23277158 | 0.97 | KDM4E (0.47) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Bromide SCHEMBL11016656 | 0.97 | TSHR (0.41) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| SCHEMBL361099 | 0.93 | TSHR (0.44) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| SCHEMBL133755 | 0.93 | TSHR (0.44) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Bromide SCHEMBL970342 | 0.90 | TSHR (0.41) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Bromide SCHEMBL303901 | 0.90 | TSHR (0.41) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Fluoride Ion SCHEMBL19812466 | 0.90 | TSHR (0.41) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Iodide SCHEMBL3467912 | 0.90 | TSHR (0.41) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Hydrochloric Acid SCHEMBL1311617 | 0.90 | KDM4E (0.47) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Hydrochloric Acid SCHEMBL78546 | 0.90 | KDM4E (0.47) | TSHRNFKB1KCNA1KDM4EPMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3419753-B1 | QUATERNARY AMMONIUM SULFUR-CONTAINING BINUCLEAR MOLYBDATE SALTS AS LUBRICANT ADDITIVES | VANDERBILT CHEMICALS LLC (US) | 2023-07-12 | — | — | EP | claimed |
| US-10590364-B2 | Quaternary ammonium sulfur-containing binuclear molybdate salts as lubricant additives | VANDERBILT CHEMICALS, LLC (US) | 2020-03-17 | — | — | US | claimed |
| EP-3419753-A1 | QUATERNARY AMMONIUM SULFUR-CONTAINING BINUCLEAR MOLYBDATE SALTS AS LUBRICANT ADDITIVES | Vanderbilt Chemicals, LLC (US) | 2019-01-02 | — | — | EP | claimed |
| US-20180327685-A1 | Quaternary Ammonium Sulfur-Containing Binuclear Molybdate Salts as Lubricant Additives | VANDERBILT CHEMICALS LLC (US) | 2018-11-15 | — | — | US | claimed |
| WO-2017146939-A1 | QUATERNARY AMMONIUM SULFUR-CONTAINING BINUCLEAR MOLYBDATE SALTS AS LUBRICANT ADDITIVES | VANDERBILT CHEMICALS, LLC (US) | 2017-08-31 | — | — | WO | claimed |
| US-20170240838-A1 | QUATERNARY AMMONIUM SULFUR-CONTAINING BINUCLEAR MOLYBDATE SALTS AS LUBRICANT ADDITIVES | VANDERBILT CHEMICALS, LLC (US) | 2017-08-24 | — | — | US | claimed |
| EP-1619742-B1 | Ion-polymer gel electrolyte and its precursor composition | DAI ICHI KOGYO SEIYAKU CO LTD (JP) | 2011-02-23 | — | — | EP | claimed |
| US-7279540-B2 | Ion-polymer gel electrolyte and its precursor composition | DAI-ICHI KOGYO SEIYAKU CO., LTD. (JP) | 2007-10-09 | — | — | US | claimed |
| US-4287172-A | POLYMERS OF DIALLYLAMMONIUM SALTS | L'OREAL (FR) | 1981-09-01 | — | — | US | claimed |
| US-20230373173-A1 | MONOLITHIC HIGH REFRACTIVE INDEX PHOTONIC DEVICES | CITIBANK, N.A., AS COLLATERAL AGENT | 2023-11-23 | — | — | US | disclosed |
| WO-2020059748-A1 | RESIN COMPOSITION, MOLDED BODY, AND APPLICATION THEREOF | 三菱瓦斯化学株式会社 | 2020-03-26 | — | — | WO | disclosed |
| WO-2020059749-A1 | STRETCHED BODY, PET BOTTLE AND CONTAINER MANUFACTURING METHOD | 三菱瓦斯化学株式会社 | 2020-03-26 | — | — | WO | disclosed |
| WO-2020031836-A1 | POLYMERIZABLE IONIC LIQUID, POLYMER, CURABLE COMPOSITION, ELECTROCHEMICAL ELEMENT MATERIAL, AND ANTISTATIC MATERIAL | セントラル硝子株式会社 | 2020-02-13 | — | — | WO | disclosed |
| EP-2660292-B1 | POLYAMIDE COMPOSITION | MITSUBISHI GAS CHEMICAL CO (JP) | 2017-06-07 | — | — | EP | disclosed |
| EP-1308478-A1 | Polyamide resin composition | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2003-05-07 | — | — | EP | disclosed |
| US-6515099-B2 | Preventing thermal degradation and gelation by regulating the melt-kneading of a m-xylylenediamine/acyclic dicarboxylic acid-based polyamide and a layered silicate treated with an organic swelling agent; packaging foods; films; barriers | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2003-02-04 | — | — | US | disclosed |
| US-20010056148-A1 | Shaped article of polyamide resin and production thereof | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2001-12-27 | — | — | US | disclosed |
| EP-1156073-A1 | Shaped article of polyamide resin and production thereof | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2001-11-21 | — | — | EP | disclosed |
| US-4426375-A | DIALLYLAMINE DERIVATIVES | L'OREAL (FR) | 1984-01-17 | — | — | US | disclosed |
| US-4287172-A | POLYMERS OF DIALLYLAMMONIUM SALTS | L'OREAL (FR) | 1981-09-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10590364-B2 | Quaternary ammonium sulfur-containing binuclear molybdate salts as lubricant additives | ATXN10, MDM4, OR10J3 | TSHR 3298/4885NFKB1 697/4885KCNA1 2485/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.